MTOR Signaling at a Glance

Overview

Journal J Cell Sci

Specialty Cell Biology

Date 2009 Oct 9

PMID 19812304

Citations 1149

Authors

Mathieu Laplante

David M Sabatini

Affiliations

Soon will be listed here.

Citing Articles

Targeting EGFR and PI3K/mTOR pathways in glioblastoma: innovative therapeutic approaches.

Singh G, Rohit , Kumar P, Aran K Med Oncol. 2025; 42(4):97.

PMID: 40064710 DOI: 10.1007/s12032-025-02652-1.

Retinoic Acid Promotes Neuronal Differentiation While Increasing Proteins and Organelles Related to Autophagy.

Lazzeri G, Lenzi P, Signorini G, Raffaelli S, Giammattei E, Natale G Int J Mol Sci. 2025; 26(4).

PMID: 40004155 PMC: 11855701. DOI: 10.3390/ijms26041691.

Everolimus in the Treatment of Neuroendocrine Tumors: Lights and Shadows.

Medici B, Caffari E, Maculan Y, Benatti S, Piacentini F, Dominici M Biomedicines. 2025; 13(2).

PMID: 40002868 PMC: 11853220. DOI: 10.3390/biomedicines13020455.

Mitochondrial Dysfunction and Its Potential Molecular Interplay in Hypermobile Ehlers-Danlos Syndrome: A Scoping Review Bridging Cellular Energetics and Genetic Pathways.

Shirvani P, Shirvani A, Holick M Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996855 PMC: 11854588. DOI: 10.3390/cimb47020134.

PTEN mutations impair CSF dynamics and cortical networks by dysregulating periventricular neural progenitors.

DeSpenza Jr T, Kiziltug E, Allington G, Barson D, McGee S, OConnor D Nat Neurosci. 2025; 28(3):536-557.

PMID: 39994410 DOI: 10.1038/s41593-024-01865-3.

References

Ganley I, Lam D, Wang J, Ding X, Chen S, Jiang X . ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J Biol Chem. 2009; 284(18):12297-305. PMC: 2673298. DOI: 10.1074/jbc.M900573200. View

Guertin D, Sabatini D . Defining the role of mTOR in cancer. Cancer Cell. 2007; 12(1):9-22. DOI: 10.1016/j.ccr.2007.05.008. View

Sancak Y, Peterson T, Shaul Y, Lindquist R, Thoreen C, Bar-Peled L . The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science. 2008; 320(5882):1496-501. PMC: 2475333. DOI: 10.1126/science.1157535. View

Nicklin P, Bergman P, Zhang B, Triantafellow E, Wang H, Nyfeler B . Bidirectional transport of amino acids regulates mTOR and autophagy. Cell. 2009; 136(3):521-34. PMC: 3733119. DOI: 10.1016/j.cell.2008.11.044. View

Choo A, Yoon S, Kim S, Roux P, Blenis J . Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proc Natl Acad Sci U S A. 2008; 105(45):17414-9. PMC: 2582304. DOI: 10.1073/pnas.0809136105. View

Inoki K, Li Y, Zhu T, Wu J, Guan K . TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol. 2002; 4(9):648-57. DOI: 10.1038/ncb839. View

Wouters B, Koritzinsky M . Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer. 2008; 8(11):851-64. DOI: 10.1038/nrc2501. View

Sarbassov D, Guertin D, Ali S, Sabatini D . Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 2005; 307(5712):1098-101. DOI: 10.1126/science.1106148. View

Li Y, Wang Y, Kim E, Beemiller P, Wang C, Swanson J . Bnip3 mediates the hypoxia-induced inhibition on mammalian target of rapamycin by interacting with Rheb. J Biol Chem. 2007; 282(49):35803-13. DOI: 10.1074/jbc.M705231200. View

10.

Kim J, Chen J . regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes. 2004; 53(11):2748-56. DOI: 10.2337/diabetes.53.11.2748. View

11.

Lawlor M, Alessi D . PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?. J Cell Sci. 2001; 114(Pt 16):2903-10. DOI: 10.1242/jcs.114.16.2903. View

12.

Brugarolas J, Lei K, Hurley R, Manning B, Reiling J, Hafen E . Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 2004; 18(23):2893-904. PMC: 534650. DOI: 10.1101/gad.1256804. View

13.

Jacinto E, Facchinetti V, Liu D, Soto N, Wei S, Jung S . SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell. 2006; 127(1):125-37. DOI: 10.1016/j.cell.2006.08.033. View

14.

Huffman T, Mothe-Satney I, Lawrence Jr J . Insulin-stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin. Proc Natl Acad Sci U S A. 2002; 99(2):1047-52. PMC: 117427. DOI: 10.1073/pnas.022634399. View

15.

Foster D . Regulation of mTOR by phosphatidic acid?. Cancer Res. 2007; 67(1):1-4. DOI: 10.1158/0008-5472.CAN-06-3016. View

16.

Manning B . Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. J Cell Biol. 2004; 167(3):399-403. PMC: 2172491. DOI: 10.1083/jcb.200408161. View

17.

Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, Zhang X . TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell. 2006; 126(5):955-68. DOI: 10.1016/j.cell.2006.06.055. View

18.

Schieke S, Phillips D, McCoy Jr J, Aponte A, Shen R, Balaban R . The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem. 2006; 281(37):27643-52. DOI: 10.1074/jbc.M603536200. View

19.

Kim E, Goraksha-Hicks P, Li L, Neufeld T, Guan K . Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol. 2008; 10(8):935-45. PMC: 2711503. DOI: 10.1038/ncb1753. View

20.

Lee D, Kuo H, Chen C, Hsu J, Chou C, Wei Y . IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell. 2007; 130(3):440-55. DOI: 10.1016/j.cell.2007.05.058. View